Predict your next investment

Venture Capital
pappas-capital.com

See what CB Insights has to offer

Investments

148

Portfolio Exits

46

Funds

11

Partners & Customers

2

About Pappas Ventures

Pappas Ventures is focused exclusively on investing in the life sciences sector across North America. Its entire team works closely with our portfolio companies and investors to deliver superior results for everyone involved. The firm invests solely in the life sciences - biotechnology, specialty pharmaceuticals, drug delivery, diagnostics, medical devices and related ventures.

Pappas Ventures Headquarter Location

2520 Meridian Parkway Suite 400

Durham, North Carolina, 27713,

United States

919-998-3300

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Pappas Ventures News

Triangle Inno - Durham's Pappas Ventures launches $250M fund - The Business Journals

Mar 19, 2022

Business Journals Not a member yet? Breaking News 24/7/365 ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY.CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN.PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.THIS IS NOT A SOLICITATION FOR INVESTMENT.THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY.IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES.ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM.PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT. ALPHAMAVEN

Pappas Ventures Investments

148 Investments

Pappas Ventures has made 148 investments. Their latest investment was in NuProbe as part of their Series B on June 6, 2022.

CBI Logo

Pappas Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/2/2022

Series B

NuProbe

$50M

Yes

4

4/14/2022

Series A

Us2.ai

$15M

Yes

1

3/16/2022

Series B

Lindy Biosciences

$3.26M

Yes

3

2/23/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

1/5/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/2/2022

4/14/2022

3/16/2022

2/23/2022

1/5/2022

Round

Series B

Series A

Series B

Series B

Series A

Company

NuProbe

Us2.ai

Lindy Biosciences

Subscribe to see more

Subscribe to see more

Amount

$50M

$15M

$3.26M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

1

3

10

10

Pappas Ventures Portfolio Exits

46 Portfolio Exits

Pappas Ventures has 46 portfolio exits. Their latest portfolio exit was Aura Biosciences on October 29, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/29/2021

IPO

$99M

Public

10

4/28/2021

Acquired

$99M

8

4/9/2021

IPO

$99M

Public

2

12/16/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/11/2020

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/29/2021

4/28/2021

4/9/2021

12/16/2020

12/11/2020

Exit

IPO

Acquired

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

10

8

2

10

10

Pappas Ventures Fund History

11 Fund Histories

Pappas Ventures has 11 funds, including Asia Innovation Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/17/2021

Asia Innovation Fund

1

1/15/2019

A.M. Pappas Life Science Ventures V LP

Early-Stage Venture Capital

Closed

$86M

1

1/15/2019

PV V CEO Fund

$6.96M

2

1/4/2018

A. M. Pappas Life Science Ventures V

10

10/7/2015

WFBMC/Catalyst Fund

$99M

10

Closing Date

9/17/2021

1/15/2019

1/15/2019

1/4/2018

10/7/2015

Fund

Asia Innovation Fund

A.M. Pappas Life Science Ventures V LP

PV V CEO Fund

A. M. Pappas Life Science Ventures V

WFBMC/Catalyst Fund

Fund Type

Early-Stage Venture Capital

Status

Closed

Amount

$86M

$6.96M

$99M

Sources

1

1

2

10

10

Pappas Ventures Partners & Customers

2 Partners and customers

Pappas Ventures has 2 strategic partners and customers. Pappas Ventures recently partnered with SAS on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/20/2021

Partner

United States

SAS and Pappas Capital collaborate to grow AgTech industry with software, guidance, and leadership

CARY -- Through a newly announced partnership , SAS and Pappas Capital will work together with the goal of ensuring that North Carolina is a leader in agricultural technology for decades to come .

3

10/20/2021

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

10/20/2021

10/20/2021

Type

Partner

Partner

Business Partner

Country

United States

United States

News Snippet

SAS and Pappas Capital collaborate to grow AgTech industry with software, guidance, and leadership

CARY -- Through a newly announced partnership , SAS and Pappas Capital will work together with the goal of ensuring that North Carolina is a leader in agricultural technology for decades to come .

Subscribe to see more

Subscribe to see more

Sources

3

10

Pappas Ventures Team

11 Team Members

Pappas Ventures has 11 team members, including current Chief Executive Officer, Managing General Partner, Arthur M. Pappas.

Name

Work History

Title

Status

Arthur M. Pappas

Chief Executive Officer, Managing General Partner

Current

Matthew A Boyer

Chief Financial Officer

Current

Taylor Caldwell

Controller

Current

Glenn Wallace

Controller

Current

Kyle Rasbach

Managing Partner

Current

Name

Arthur M. Pappas

Matthew A Boyer

Taylor Caldwell

Glenn Wallace

Kyle Rasbach

Work History

Title

Chief Executive Officer, Managing General Partner

Chief Financial Officer

Controller

Controller

Managing Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.